Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Author:
Affiliation:
1. Department of Interventional Ultrasound; Chinese PLA General Hospital; Beijing 100853 China
2. Key Laboratory of Molecular Imaging, Institute of Automation; Chinese Academy of Sciences; Beijing 100190 China
Funder
National Natural Science Foundation of China
National Science and Technology Major Project of China
Publisher
Wiley
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Reference177 articles.
1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015
2. Hepatocellular carcinoma;Forner;Lancet,2012
3. Drug delivery system targeting advanced hepatocellular carcinoma: Current and future;Zhang;Nanomedicine,2016
4. Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma;Shirakawa;Cancer Sci,2009
5. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling;Midorikawa;Int J Cancer,2003
Cited by 249 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. TopMarker: Computational screening biomarkers of hepatocellular carcinoma from transcriptome and interactome based on differential network topological parameters;Computational Biology and Chemistry;2024-10
2. ZFC3H1 as an Indicator of Poor Prognosis in Hepatocellular Carcinoma: Bioinformatic Analysis and Experimental Verification;Combinatorial Chemistry & High Throughput Screening;2024-08-02
3. A dual-signal output electrochemical aptasensor for glypican-3 ultrasensitive detection based on reduced graphene oxide-cuprous oxide nanozyme catalytic amplification strategy;Bioelectrochemistry;2024-08
4. Exploring Glypican-3 as a Molecular Target in Hepatocellular Carcinoma: Perspectives on Diagnosis and Precision Immunotherapy Strategies;Frontiers in Bioscience-Landmark;2024-07-24
5. GPC2 promotes prostate cancer progression via MDK-mediated activation of PI3K/AKT signaling pathway;Functional & Integrative Genomics;2024-07-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3